DimethylritrosamineÀÇ ¹Ýº¹Åõ¿©°¡ ¹é¼­°£Àå¿¡ ¹ÌÄ¡´Â º´¸®Á¶Á÷ÇÐÀû ¿¬±¸

Histopathologic Effects of Repeated Treatment of Dimethylnitrosamine on Rat Liver

ÀúÀÚ : °­¿µÃµ

À§¾Ï¿¡ À־ ±¹¼ÒÀÓÆÄÀýÀÇ ¹ÝÀÀ¿¡ ´ëÇÑ º´¸®Á¶Á÷ÇÐÀû ¿¬±¸

Histopathologic Study of the Regional Lymph Node Reactivity in Gastric Carcinoma

ÀúÀÚ : ³²ÇýÁÖ

AdriamycinÀÇ Cardiotoxicity¿¡ ´ëÇÑ ½ÇÇèÀû ¿¬±¸

Experimental Study of Adriamycin Cardiotoxicity in Rabbits

ÀúÀÚ : º¯¿µ¼ö

»ç¿°È­Åº¼ÒÀÇ ¹Ýº¹Åõ¿©¿¡ ÀÇÇÑ ¹é¼­°£ÀåÀÇ º´¸®Á¶Á÷ÇÐÀû º¯È­

Effects of Repeated Treatment of Carbon Tetrachloride of Histopathologic Changes of Liver in Rats

ÀúÀÚ : ¼­ÇýÁø

Àúü¿Â °³½É¼ú½Ã Ç÷´ç ¹× ÀüÇØÁúÄ¡ÀÇ º¯È­¿¡ °üÇÑ ¿¬±¸

Changes in Blood Glucose and Electrolyte During Open Heart Surgery

ÀúÀÚ : À¯º´·Ä

°Ç¼±¿¡ À־ Á¶Á÷¼Ò°ß°ú ºñ¸¸¼¼Æ÷¼öÀÇ º¯È­¿¡ °üÇÑ °üÂû

Study of Relationship between Histologic Findings and Variation of Number of Mast Cell in Psoriasis

ÀúÀÚ : ¹®º´Ãµ

X-¼± Àü½ÅÁ¶»ç¿¡ ÀÇÇÑ ¹é¼­ °£Á¶Á÷ÀÇ ±Þ¼ºº¯È­¿¡ ´ëÇÑ º´¸®Á¶Á÷ÇÐÀû ¿¬±¸

Histopathologic Study on the Acute Changes of Liver Tissue after Whole Body Irradiation

ÀúÀÚ : °­´ö½Ä

½ÇÇ赿¹°¿¡ À¯¹ß½ÃŲ ÇǺλç»ó±ÕÁõÀÇ º´¸®Á¶Á÷ÇÐÀû º¯È­¿¡ °üÇÑ ¿¬±¸

Hostopathological Changes in Experimental Dermatophytosis in Rabbits

ÀúÀÚ : Ȳ°è¿µ

À§¾ÏȯÀÚ¿¡ À־ À§¼±ÀÇ À§Ãà¿¡ °üÇÑ ¿¬±¸

Atrophic Change of Gastric Gland in Gastric Carcinomas

ÀúÀÚ : ÀÌÁ¾¸é

HPV°¨¿°°ú ÀڱðæºÎ »óÇdz» Á¾¾ç°úÀÇ »ó°ü°ü°è¿¡ ´ëÇÑ º´¸®Á¶Á÷ ¹× ¼¼Æ÷ÇÐÀû ¿¬±¸

Human papillomavirus nfection and its relationship to cervical intraepithelial neoplasia : An immunohistochemical, histopathological and cytological study

ÀúÀÚ : ±è¹ÌÁø

TrichloroethyleneÀÌ ÆóÀå Clara¼¼Æ÷ÀÇ ¹Ì¼¼±¸Á¶¿¡ ¹ÌÄ¡´Â ¿µÇâ

Effect of trichloroethylene on fine structure of Clara cells in lung

ÀúÀÚ : ³²ÇýÁÖ

À§ÀåÁúȯ¿¡ À־ IgA¿Í Secretory ComponentÀÇ ÃâÇöµµ¿¡ ´ëÇÑ ¸é¿ª Á¶Á÷ÇÐÀû ºñ±³ °üÂû

A comparative study between localization of IgA and seoretory component in gastric diseases

ÀúÀÚ : ÃÖÁØÇõ

»ç¿°È­Åº¼Ò Åõ¿©°¡ DimethylnitrosamineÀÇ ±Þ¼ºÁßµ¶ °£¼¼Æ÷ÀÇ ±¸Á¶¿¡ ¹ÌÄ¡´Â ¿µÇâ

Effects of carbon tetrachloride on structures in hepatocy-tes following DMN induced hepatotoxicity

ÀúÀÚ : °­¿µÃµ

PhenobarbitalÀüóġ°¡ »ç¿°È­Åº¼Ò ±Þ¼º Áßµ¶ Èò Áã °£¼¼Æ÷ÀÇ ±¸Á¶¿¡ ¹ÌÄ¡´Â ¿µÇâ

Effects of phenobarbital pretreatment on the hepatotoxi-city of carbon tetrachloride in rat

ÀúÀÚ : º¯¿µ¼ö

½ÇÇèÀû °£¼¶À¯È­¿¡¼­ Fat-Storing CellÀÇ ¹Ì¼¼±¸Á¶ÀÇ º¯È­¿¡ ´ëÇÑ ¿¬±¸

Ultrastructural changes of fat-storing cells in experimental hepatic fibrosis

ÀúÀÚ : ±è¹ÌÁø

³»µ¶¼Ò Åõ¿©¿¡ ÀÇÇÑ Kupffer ¼¼Æ÷ÀÇ ¹Ì¼¼ÇüÅÂÇÐÀû Çص¶¹ÝÀÀ

Fine Structure and Detoxification Kinetics in Kupffer Cells afte Injection of Endotoxin in Rats

ÀúÀÚ : ÃÖÁØÇõ

´ëÀå¾Ï¿¡¼­ ¾ÏÀ¯ÀüÀÚ »ê¹°ÀÇ ¹ßÇö

Expression of Oncogene Product in the Colorectal Carcinoma

ÀúÀÚ : ½É¿µ¶õ

À¯¹æ¾Ï¿¡¼­ p53, c-erbB-2 ¹× epidermal growth factor receptorÀÇ ¹ßÇö

Expression of p53, c-erbB-2 and Epidermal Growth Factor Receptor in Breast Carcinoma

ÀúÀÚ : ÀÌÀºÈñ

°£¼¼Æ÷¾Ï¿¡¼­ p53 ´Ü¹é¹ßÇö

The Aberrant Expression of p53 Protein in Liver Cell Carcinima

ÀúÀÚ : Àå¿ì¿µ

ÇǺΠ¸á¶ó´Ñ ¼¼Æ÷¼º º´º¯¿¡¼­ µ¹¿¬º¯ÀÌ p53´Ü¹é°ú Bc1-2 ´Ü¹éÀÇ ¹ßÇö

Expression of mutated p53 and Bc1-2 Protein in Melanocytic lesions of skin

ÀúÀÚ : ÀÌÈ­Áø

¼º»ó±³¼¼Æ÷Á¾¿¡¼­ p53À¯ÀüÀÚÀÇ µ¹¿¬º¯ÀÌ

p53 Gene Mutation in Astrocytoma : Detection by polymerase chain reaction and direct DNA sequencing

ÀúÀÚ : ÃÖ°æÂù

À¯¹æ¾Ï¿¡¼­ ½Å»ýÇ÷°üÇü¼º°ú Cathepsin-DÀÇ ¹ßÇö

ÀÚüÁ¦ÀÛ¿ø¹®

Tumor Angiogenesis and Cathepsin-D Expression in Invasive Ductal Carcinoma of the Breast

ÀúÀÚ : ¹è¿µ°æ

ÇǺΠ¾Ç¼º Èæ»öÁ¾¿¡¼­ ¸é¿ªÁ¶Á÷È­ÇÐ°Ë»ç ¼Ò°ß°ú p53 À¯ÀüÀÚ º¯ÀÌ ´Ü¹éÀÇ °ËÃâ

Immunohistocjemical analysis and Detection of the Mutant p53 protein by PCR in Cutaneous Malignant Melanoma

ÀúÀÚ : Â÷±ÔÈ£

°áÀå¾Ï ¹× Á÷Àå¾Ï¿¡¼­ p53 À¯ÀüÀÚ µ¹¿¬º¯ÀÌÀÇ ¿°±â¼­¿­

Nucleotide Sequences of Mutant p53 Gene in Colorectal Carcinomas

ÀúÀÚ : ½É¿µ¶õ

°£¼¼Æ÷¾Ï¿¡¼­ p53 À¯ÀüÀÚÀÇ µ¹¿¬º¯ÀÌ

p53 Mutation in Hepatocellular Carcinomas

ÀúÀÚ : ÀÌ»ó¶ô

½Å¼¼Æ÷¾ÏÁ¾ÀÇ ¿¹ÈÄÀÎÀڷμ­ Rb ¹× p53 ´Ü¹é¹ßÇö°ú º´±â ¹× ÇÙµî±Þ°úÀÇ ºñ±³

Comparison of Rb and p53 Protein Expression with Stage and Grade as a Prognostic Value in Renal Cell Carcinoma

ÀúÀÚ : ÃÖÇýÁ¤

À¯¹æ¾Ï¿¡¼­ Á¶Á÷³» ±³Àâ¹ýÀ» ÀÌ¿ëÇÑ telomerase mRNAÀÇ ¹ßÇö

Telomerase mRNA Expression by In Situ Hybridization in Breast Cancer

ÀúÀÚ : ¹è¿µ°æ

ÈĵΠÆíÆò»óÇǾÏÁ¾ÀÇ ¸é¿ªÁ¶Á÷ ¹× À¯¼¼Æ÷ ºÐ¼®À» ÀÌ¿ëÇÑ Áõ½Ä´É ºÐ¼®

ÀúÀÚ : ±Ç¿µÈÆ

ºÐÀý¼º »ç±¸Ã¼ °æÈ­ÁõÀÇ ÇüÅÂÇÐÀû ÁøÇà¿¡ µû¸¥ ºÐÀÚ »ý¹°ÇÐÀû º¯È­

»ó¼¼º¸±â

Molecular Biologic Changes during Morphologic Progression of the Focal Segmental Glomerulosclerosis

ÀúÀÚ : ÀÌÀºÈñ

°£³»´ã°ü¾ÏÁ¾¿¡¼­ÀÇ p53, Rb, Bcl-2 ´Ü¹é ¹ßÇö ¹× Ki-67 Ç¥ÁöÁö¼öÀÇ ÀÇÀÇ

»ó¼¼º¸±â

Expression of p53, Rb, bcl-2 Protein and Ki-67 Labeling Index in Intrahepatic Cholangiocarcinoma

ÀúÀÚ : ±¸¹ÌÁø

ÇãÇ÷/Àç°ü·ù ½Å¼Õ»óÀÇ È¸º¹¿¡¼­ Áö¹æÀ¯·¡¼ºÃ¼Áٱ⼼Æ÷ÀÇ ¿ªÇÒ

»ó¼¼º¸±â

The?role of adipose tissue-derived adult stem cells in recovery phase of the ischemia/reperfusion-induced renal injury

ÀúÀÚ : ¼º¿ìÁ¤

¿ø¹ß¼ºÆó¾Ï¿¡¼­ ¸é¿ªÁ¶Á÷È­ÇРǥÁöÀÚ ¹× epidermal growth factor receptor (EGFR) ¹ßÇö°ú EGFR µ¹¿¬º¯ÀÌ¿ÍÀÇ °ü°è

»ó¼¼º¸±â

The expression of an immunohistochemical markers and epidermal growth factor receptor (EGFR), and its relationship with genomic mutation of EGFR in primary lung cancer

ÀúÀÚ : ¼®»óÈñ

CHIP¿¡ ÀÇÇÑ Doxorubicin À¯µµ ½É±Ù¼¼Æ÷ »ç¸êÀÇ º¸È£È¿°ú

»ó¼¼º¸±â

Decreased doxorubicin-induced cardiotoxicity by CHIP

ÀúÀÚ : ±è´ö¿µ

À¯¹æ¾Ï¿¡¼­ TOP2A À¯ÀüÀÚ º¯ÀÌ¿Í HER2 À¯ÀüÀÚ º¯ÀÌ¿ÍÀÇ °ü·Ã¼º

»ó¼¼º¸±â

Topoisomerase ¥± alpha (TOP2A) gene alteration and its correlation with HER2 gene status in breast cancer

ÀúÀÚ : ±è¾Ö¸®

¸¸¼º½ÅÁúȯ µ¿¹°¸ðµ¨¿¡¼­ Àü»çÀÎÀÚ Smad ¹× Sp1 ¹ßÇöÀÌ »óÇÇ-±âÁú¼¼Æ÷Àüȯ °úÁ¤°ú ½Å¼¶À¯È­¿¡ ¹ÌÄ¡´Â ¿µÇâ

»ó¼¼º¸±â

The effects on renal fibrosis related with epithelial-mesenchymal transition through the regulation of Smad and Sp1 by using synthetic chimeric oligodeoxynucleotide in chronic kidney disease model

ÀúÀÚ : ¼º¿ìÁ¤

½ÃŬ·Î½ºÆ÷¸° ½ÅÀ庴Áõ ¸ðµ¨¿¡¼­ ¼¼Æ÷ÀÚ¸ê»ç ¾àµ¶È­¸¦ À§ÇÑ ·¹½ºº£¶óÆ®·ÑÀÇ ¿ªÇÒ

»ó¼¼º¸±â

The Resveratrol Attenuates the Apoptosis in Cyclosporine Nephropathy Model

ÀúÀÚ : ±è¼º¹Î

Çѱ¹ÀÎ »ïÁßÀ½¼ºÀ¯¹æ¾Ï¿¡¼­ EGFR À¯ÀüÀÚ µ¹¿¬º¯ÀÌ ºóµµ

»ó¼¼º¸±â

Incidence of EGFR Gene Mutation in Korean Triple-Negative Breast Cancer

ÀúÀÚ : ±è¾Ö¸®

Æó»ù¾ÏÁ¾¿¡¼­ EGFR À¯ÀüÀÚ º¹Á¦¼öº¯ÀÌ¿Í µ¹¿¬º¯ÀÌ, ´Ü¹é¹ßÇö ¹× ÀÓ»óº´¸®ÇÐÀû º¯¼ö¿ÍÀÇ »ó°ü°ü°è

»ó¼¼º¸±â

Relationship between EGFR gene copy number variation and EGFR mutations, protein expression, and clinicopathologic parameters in lung adenocarcinoma

ÀúÀÚ : ½ÅÇüÂù

À¯¹æ¾Ï¿¡¼­ ¸é¿ªÁ¶Á÷È­Çп°»öÀ» ÀÌ¿ëÇÑ ³ëÈ­°ü·ÃºÐºñÇ¥ÇöÇü ¹ßÇö°ú Á¾¾ç¹Ì¼¼È¯°æ ¹× ÀÓ»óº´¸®ÇÐÀû ÀÎÀÚµé°úÀÇ °ü·Ã¼º

»ó¼¼º¸±â

Expression of senescence-associated secretory phenotype by immunohistochemistry and its relationship with tumor microenvironment and clinicopathologic features in invasive breast cancer

ÀúÀÚ : ¹Ú¹ÎÈñ

Clinical impact of the Updated American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) Guidelines on HER2 test in Breast Cancer: Comparison of 2007, 2013 and 2018 guidelines

»ó¼¼º¸±â

HER2 À¯ÀüÀÚ °Ë»çÀÇ ASCO/CAP °¡À̵å¶óÀÎ º¯È­°¡ ȯÀÚ Ä¡·á¿¡ ¹ÌÄ¡´Â ¿µÇâ: 2007, 2013 ¹× 2018 °¡À̵å¶óÀο¡ µû¸¥ À¯ÀüÀÚ°Ë»ç °á°ú ºñ±³

ÀúÀÚ : ±è¹ÎÁ¾

Tumor budding in advanced gastric adenocarcinoma: prognostic value and recommendation of new scoring criteria for tumor budding assessment

»ó¼¼º¸±â

ÁøÇ༺ À§»ù¾ÏÁ¾¿¡¼­ÀÇ Á¾¾ç¹ß¾Æ: ¿¹ÈÄÀû Á߿伺 ¹× Á¾¾ç¹ß¾ÆÀÇ »õ·Î¿î Á¡¼öü°èÀÇ Á¦¾È

ÀúÀÚ : ±ÇÈñÁ¤